Observational studyBMC cancer2025

Combination of chemotherapy and immune checkpoint inhibitors in non-small cell lung cancer with actionable gene alterations other than EGFR, ALK, and ROS1 mutations: a retrospective observational study.

Ji Eun Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.